U.S. Markets closed

Gilead Sciences’ Cash Flows, Valuations, and Price Performance

Kenneth Smith
Gilead Sciences’ Cash Flows, Valuations, and Price Performance

Gilead Sciences (GILD) stock has corrected 9.6% since the start of 2018 to close at $66.99 on May 15. In comparison, Johnson & Johnson (JNJ), Pfizer (PFE), and Merck & Co. (MRK) have returned -9.5%, -2.1%, and 5.3%, respectively.